This information is not medical advice and is not a substitute for diagnosis or treatment by a physician.Data sources and disclaimers (data limitations, copyright, etc.)The analysis on "Effects of allopurinol injection: A Synthesis of Findings from 34 Studies" on this page is based on PubMed data provided by the U.S. National Library of Medicine (NLM). However, NLM does not endorse or verify these analyses.

This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.

This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Effects of allopurinol injection: A Synthesis of Findings from 34 Studies", please consult your doctor.

For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to Dataset
Please check the disclaimer.
This page's analysis is based on PubMed data provided by the U.S. National Library of Medicine (NLM).
Original Abstract of the Article

Main Research Findings

The provided research articles focus primarily on the effects of albuterol, a common bronchodilator used to treat asthma, in various contexts and patient populations.

One study compared the immediate effects of nebulized isoetharine and albuterol in treating severe asthma exacerbations. It found that while isoetharine had a faster initial effect, the difference was negligible after one hour. However, isoetharine was associated with more side effects. 19

Another study investigated the dose-response effects of albuterol aerosol compared to isoproterenol and placebo. It found that albuterol was an effective bronchodilator with minimal side effects even at higher doses, and its effects lasted longer than isoproterenol. 1

Several studies focused on the adverse effects of beta-agonists like albuterol, including increased risk of death and exacerbations in some cases. 30 However, the study also noted that long-acting beta-agonists like salmeterol did not have the same association with increased asthma mortality. 30

The effects of therapeutic doses of inhaled albuterol on beta2-adrenergic receptor density and metabolic changes were studied, demonstrating no significant changes at those doses. 27

A study explored the long-term effects of albuterol in patients with cystic fibrosis, suggesting potential benefits for lung function. 24

The efficacy and safety of albuterol syrup in treating asthma in children aged 2 to 6 years were evaluated, demonstrating improved control of severe asthma. 13

The effectiveness of continuous versus intermittent nebulized albuterol administration for acute asthma was investigated, suggesting potential benefits for continuous nebulization. 17

A study compared the relative efficacy of theophylline and inhaled albuterol for chronic asthma, finding that theophylline provided longer-lasting effects. 12

Research compared inhaled levalbuterol and albuterol for acute asthma, finding no significant difference in efficacy or safety. 33

The study explored the effect of nebulized albuterol on early and late asthmatic responses. 3

The efficacy and safety of nebulized albuterol in treating acute bronchiolitis in infants were investigated. 5

The effectiveness of combined glycopyrrolate and albuterol treatment for acute asthma exacerbations was examined. 18

A study compared regularly scheduled versus as-needed albuterol use in mild asthma. 22

Albuterol was compared to isoproterenol as a bronchodilator in pulmonary function testing, finding no significant difference in potency or speed of action. 4

The effects of albuterol and terbutaline administered by metered-dose inhaler were compared, finding no significant difference in pulmonary response or side effects. 9

The optimal dose and effect of nebulized albuterol in acute exacerbations of COPD were investigated. 31

The effects of high-dose inhaled albuterol in severe chronic airflow limitation were studied. 6

A study compared the effects of Bricanyl Turbuhaler and Ventolin metered dose inhaler in treating exercise-induced asthma. 2

Albuterol and isoproterenol were compared in terms of their acute effects on cardiopulmonary function and gas exchange in asthmatic children. 15

The study explored the concept of partial versus full beta-receptor agonism with inhaled albuterol and fenoterol. 20

The study investigated the effects of prior diuretic treatment on the hypokalemic and electrocardiographic effects of inhaled albuterol. 8

A study compared the therapeutic ratios of R-albuterol and RS-albuterol in asthmatic patients. 29

Oral albuterol was evaluated for the treatment of childhood asthma. 16

The effects of an inhaled beta(2)-adrenergic agonist on lower esophageal function were investigated. 28

A study examined the beneficial effects of albuterol therapy delivered by heliox versus oxygen in severe asthma exacerbations. 32

The effect of regular salmeterol treatment on albuterol-induced bronchoprotection in mild asthma was investigated. 23

A study compared inhaled albuterol powder and aerosol in asthma. 7

The potential for tolerance to albuterol after treatment with salmeterol in patients with asthma was assessed. 25

A dose-response evaluation of levalbuterol versus racemic albuterol in patients with asthma was conducted. 26

A comparison of inhaled fenoterol and albuterol in asthma was undertaken. 14

The effects of high-versus low-dose, frequently administered, nebulized albuterol in children with severe, acute asthma were investigated. 10

The effectiveness of continuous versus intermittent albuterol at high and low doses for severe acute asthma in adults was compared. 21

The efficacy and safety of aerosolized albuterol and a dry powder formulation were compared. 11

Benefits and Risks

Benefits Summary

Albuterol is generally considered safe and effective for treating asthma in various forms and severity, including acute exacerbations, chronic asthma, and exercise-induced asthma. 19 , 1 , 30 , 27 , 24 , 13 , 17 , 12 , 33 , 3 , 5 , 18 , 22 , 4 , 9 , 31 , 6 , 2 , 15 , 20 , 8 , 29 , 16 , 28 , 32 , 23 , 7 , 25 , 26 , 14 , 10 , 21 , 11

Risks Summary

Albuterol, like many medications, has potential side effects. These can include, but are not limited to, tremors, palpitations, nervousness, headache, and muscle cramps. 19 , 1 , 30 , 27 , 24 , 13 , 17 , 12 , 33 , 3 , 5 , 18 , 22 , 4 , 9 , 31 , 6 , 2 , 15 , 20 , 8 , 29 , 16 , 28 , 32 , 23 , 7 , 25 , 26 , 14 , 10 , 21 , 11 . In rare cases, more serious adverse effects can occur. 30

Study Comparisons

Study Similarities

The majority of the studies highlight the effectiveness of albuterol as a bronchodilator for various asthma conditions and patient demographics. 19 , 1 , 30 , 27 , 24 , 13 , 17 , 12 , 33 , 3 , 5 , 18 , 22 , 4 , 9 , 31 , 6 , 2 , 15 , 20 , 8 , 29 , 16 , 28 , 32 , 23 , 7 , 25 , 26 , 14 , 10 , 21 , 11

Study Differences

The studies vary in their focus, such as comparing albuterol to other bronchodilators, investigating different delivery methods, examining long-term versus short-term effects, and exploring the drug's impact on specific patient populations like children, those with cystic fibrosis, or those with cardiovascular disease.

Consistency and Contradictions

The research generally supports albuterol's efficacy as a bronchodilator, but there are some areas where findings diverge, such as the potential for increased mortality with certain beta-agonists and the optimal dosing and delivery methods for specific situations. 19 , 30 , 17 , 33 , 10 , 21 , 11

Real-World Application Considerations

Albuterol is a common asthma medication, but its use should be guided by a healthcare professional. 30 It's important to understand the potential side effects and to follow prescribed dosage and administration instructions.

Limitations of Current Research

While research provides valuable insights, there are limitations, such as the need for larger-scale studies to explore long-term effects and safety profiles. 30 More research is also needed to determine the optimal dosing and delivery methods for different patient groups and asthma severity.

Future Research Directions

Future research should focus on better understanding the long-term effects of albuterol, including its impact on asthma control and the development of tolerance. 30 , 23 , 25 Additionally, further investigation is needed to clarify the potential risks associated with different beta-agonists, especially in vulnerable populations like children, the elderly, and those with cardiovascular disease. 30 , 15 , 16 Further study into different delivery methods, like inhalers versus nebulizers, is also important. 11

Conclusion

Albuterol is a widely used and generally effective bronchodilator for asthma. However, it's crucial to be aware of its potential side effects, to follow prescribed dosage and administration instructions, and to consult a healthcare professional for proper management of asthma. 30 Continued research is necessary to improve our understanding of albuterol's long-term effects and to identify the most effective and safe approaches for treating asthma in various populations.


Keywords
Benefit Keywords
Risk Keywords
Literature analysis of 34 papers
Positive Content
30
Neutral Content
1
Negative Content
3
Article Type
32
1
2
2
34

Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.